APO Research
Talk to an analyst

APO RESEARCH · REPORT

Congestive Heart Failure Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Congestive Heart Failure Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025195 pages

Choose your research edition.

Industry ResearchCongestive Heart Failure Drugs Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Congestive Heart Failure Drugs Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Congestive Heart Failure Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Congestive Heart Failure Drugs Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Congestive Heart Failure Drugs Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Congestive Heart Failure Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Congestive Heart Failure Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Congestive Heart Failure Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Congestive Heart Failure Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Congestive Heart Failure Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Congestive Heart Failure Drugs include Sanofi, Johnson & Johnson, Novartis, Merck & Co, Mylan, Pfizer, GSK, Bayer and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Congestive Heart Failure Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Congestive Heart Failure Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Congestive Heart Failure Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Congestive Heart Failure Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Congestive Heart Failure Drugs Segment by Company

Sanofi

Johnson & Johnson

Novartis

Merck & Co

Mylan

Pfizer

GSK

Bayer

AstraZeneca

Xudong Haipu Pharmaceutical

Xinhua Group

Sinepharm

NCPC

Lunan Pharmaceutical

Langtian

Hayao

Hai Ni Pharmaceutical

Exelixis

CRC

Bristol-Myers Squibb

Boehringer Inhelheim

Bausch Health

Congestive Heart Failure Drugs Segment by Type

Capsule

Tablets

Injection

Congestive Heart Failure Drugs Segment by Application

Clinic

Hospital

Household

Other

Congestive Heart Failure Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Congestive Heart Failure Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Congestive Heart Failure Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Congestive Heart Failure Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Congestive Heart Failure Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Congestive Heart Failure Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Congestive Heart Failure Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Congestive Heart Failure Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Congestive Heart Failure Drugs Industry Trends Table 2. Congestive Heart Failure Drugs Industry Drivers Table 3. Congestive Heart Failure Drugs Industry Opportunities and Challenges Table 4. Congestive Heart Failure Drugs Industry Restraints Table 5. Global Congestive Heart Failure Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Congestive Heart Failure Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Congestive Heart Failure Drugs Sales by Manufacturers (K Tons) & (2021-2026) Table 8. Global Congestive Heart Failure Drugs Sales Market Share by Manufacturers Table 9. Global Congestive Heart Failure Drugs Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Congestive Heart Failure Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Congestive Heart Failure Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Congestive Heart Failure Drugs Manufacturers, Product Type & Application Table 13. Global Congestive Heart Failure Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Congestive Heart Failure Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Capsule Table 17. Major Manufacturers of Tablets Table 18. Major Manufacturers of Injection Table 19. Global Congestive Heart Failure Drugs Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 20. Global Congestive Heart Failure Drugs Sales by Type (2021-2026) & (K Tons) Table 21. Global Congestive Heart Failure Drugs Sales by Type (2027-2032) & (K Tons) Table 22. Global Congestive Heart Failure Drugs Sales Market Share by Type (2021-2026) Table 23. Global Congestive Heart Failure Drugs Sales Market Share by Type (2027-2032) Table 24. Global Congestive Heart Failure Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Tons) Table 25. Global Congestive Heart Failure Drugs Revenue by Type (2021-2026) & (K Tons) Table 26. Global Congestive Heart Failure Drugs Revenue by Type (2027-2032) & (K Tons) Table 27. Global Congestive Heart Failure Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Congestive Heart Failure Drugs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Household Table 32. Major Manufacturers of Other Table 33. Global Congestive Heart Failure Drugs Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 34. Global Congestive Heart Failure Drugs Sales by Application (2021-2026) & (K Tons) Table 35. Global Congestive Heart Failure Drugs Sales by Application (2027-2032) & (K Tons) Table 36. Global Congestive Heart Failure Drugs Sales Market Share by Application (2021-2026) Table 37. Global Congestive Heart Failure Drugs Sales Market Share by Application (2027-2032) Table 38. Global Congestive Heart Failure Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Tons) Table 39. Global Congestive Heart Failure Drugs Revenue by Application (2021-2026) & (K Tons) Table 40. Global Congestive Heart Failure Drugs Revenue by Application (2027-2032) & (K Tons) Table 41. Global Congestive Heart Failure Drugs Revenue Market Share by Application (2021-2026) Table 42. Global Congestive Heart Failure Drugs Revenue Market Share by Application (2027-2032) Table 43. Global Congestive Heart Failure Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 44. Global Congestive Heart Failure Drugs Sales by Region (2021-2026) & (K Tons) Table 45. Global Congestive Heart Failure Drugs Sales Market Share by Region (2021-2026) Table 46. Global Congestive Heart Failure Drugs Sales Forecasted by Region (2027-2032) & (K Tons) Table 47. Global Congestive Heart Failure Drugs Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Congestive Heart Failure Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 49. North America Congestive Heart Failure Drugs Sales by Country (2021-2026) & (K Tons) Table 50. North America Congestive Heart Failure Drugs Sales by Country (2027-2032) & (K Tons) Table 51. Europe Congestive Heart Failure Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 52. Europe Congestive Heart Failure Drugs Sales by Country (2021-2026) & (K Tons) Table 53. Europe Congestive Heart Failure Drugs Sales by Country (2027-2032) & (K Tons) Table 54. Asia Pacific Congestive Heart Failure Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 55. Asia Pacific Congestive Heart Failure Drugs Sales by Country (2021-2026) & (K Tons) Table 56. Asia Pacific Congestive Heart Failure Drugs Sales by Country (2027-2032) & (K Tons) Table 57. South America, Middle East and Africa Congestive Heart Failure Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 58. South America, Middle East and Africa Congestive Heart Failure Drugs Sales by Country (2021-2026) & (K Tons) Table 59. South America, Middle East and Africa Congestive Heart Failure Drugs Sales by Country (2027-2032) & (K Tons) Table 60. Global Congestive Heart Failure Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Congestive Heart Failure Drugs Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Congestive Heart Failure Drugs Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Congestive Heart Failure Drugs Revenue Market Share by Region (2021-2026) Table 64. Global Congestive Heart Failure Drugs Revenue Market Share by Region (2027-2032) Table 65. Sanofi Company Information Table 66. Sanofi Business Overview Table 67. Sanofi Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Sanofi Congestive Heart Failure Drugs Product Portfolio Table 69. Sanofi Recent Development Table 70. Johnson & Johnson Company Information Table 71. Johnson & Johnson Business Overview Table 72. Johnson & Johnson Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Johnson & Johnson Congestive Heart Failure Drugs Product Portfolio Table 74. Johnson & Johnson Recent Development Table 75. Novartis Company Information Table 76. Novartis Business Overview Table 77. Novartis Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Novartis Congestive Heart Failure Drugs Product Portfolio Table 79. Novartis Recent Development Table 80. Merck & Co Company Information Table 81. Merck & Co Business Overview Table 82. Merck & Co Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Merck & Co Congestive Heart Failure Drugs Product Portfolio Table 84. Merck & Co Recent Development Table 85. Mylan Company Information Table 86. Mylan Business Overview Table 87. Mylan Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Mylan Congestive Heart Failure Drugs Product Portfolio Table 89. Mylan Recent Development Table 90. Pfizer Company Information Table 91. Pfizer Business Overview Table 92. Pfizer Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Pfizer Congestive Heart Failure Drugs Product Portfolio Table 94. Pfizer Recent Development Table 95. GSK Company Information Table 96. GSK Business Overview Table 97. GSK Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. GSK Congestive Heart Failure Drugs Product Portfolio Table 99. GSK Recent Development Table 100. Bayer Company Information Table 101. Bayer Business Overview Table 102. Bayer Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Bayer Congestive Heart Failure Drugs Product Portfolio Table 104. Bayer Recent Development Table 105. AstraZeneca Company Information Table 106. AstraZeneca Business Overview Table 107. AstraZeneca Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. AstraZeneca Congestive Heart Failure Drugs Product Portfolio Table 109. AstraZeneca Recent Development Table 110. Xudong Haipu Pharmaceutical Company Information Table 111. Xudong Haipu Pharmaceutical Business Overview Table 112. Xudong Haipu Pharmaceutical Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Xudong Haipu Pharmaceutical Congestive Heart Failure Drugs Product Portfolio Table 114. Xudong Haipu Pharmaceutical Recent Development Table 115. Xinhua Group Company Information Table 116. Xinhua Group Business Overview Table 117. Xinhua Group Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Xinhua Group Congestive Heart Failure Drugs Product Portfolio Table 119. Xinhua Group Recent Development Table 120. Sinepharm Company Information Table 121. Sinepharm Business Overview Table 122. Sinepharm Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Sinepharm Congestive Heart Failure Drugs Product Portfolio Table 124. Sinepharm Recent Development Table 125. NCPC Company Information Table 126. NCPC Business Overview Table 127. NCPC Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. NCPC Congestive Heart Failure Drugs Product Portfolio Table 129. NCPC Recent Development Table 130. Lunan Pharmaceutical Company Information Table 131. Lunan Pharmaceutical Business Overview Table 132. Lunan Pharmaceutical Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Lunan Pharmaceutical Congestive Heart Failure Drugs Product Portfolio Table 134. Lunan Pharmaceutical Recent Development Table 135. Langtian Company Information Table 136. Langtian Business Overview Table 137. Langtian Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Langtian Congestive Heart Failure Drugs Product Portfolio Table 139. Langtian Recent Development Table 140. Hayao Company Information Table 141. Hayao Business Overview Table 142. Hayao Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Hayao Congestive Heart Failure Drugs Product Portfolio Table 144. Hayao Recent Development Table 145. Hai Ni Pharmaceutical Company Information Table 146. Hai Ni Pharmaceutical Business Overview Table 147. Hai Ni Pharmaceutical Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Hai Ni Pharmaceutical Congestive Heart Failure Drugs Product Portfolio Table 149. Hai Ni Pharmaceutical Recent Development Table 150. Exelixis Company Information Table 151. Exelixis Business Overview Table 152. Exelixis Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Exelixis Congestive Heart Failure Drugs Product Portfolio Table 154. Exelixis Recent Development Table 155. CRC Company Information Table 156. CRC Business Overview Table 157. CRC Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. CRC Congestive Heart Failure Drugs Product Portfolio Table 159. CRC Recent Development Table 160. Bristol-Myers Squibb Company Information Table 161. Bristol-Myers Squibb Business Overview Table 162. Bristol-Myers Squibb Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 163. Bristol-Myers Squibb Congestive Heart Failure Drugs Product Portfolio Table 164. Bristol-Myers Squibb Recent Development Table 165. Boehringer Inhelheim Company Information Table 166. Boehringer Inhelheim Business Overview Table 167. Boehringer Inhelheim Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 168. Boehringer Inhelheim Congestive Heart Failure Drugs Product Portfolio Table 169. Boehringer Inhelheim Recent Development Table 170. Bausch Health Company Information Table 171. Bausch Health Business Overview Table 172. Bausch Health Congestive Heart Failure Drugs Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 173. Bausch Health Congestive Heart Failure Drugs Product Portfolio Table 174. Bausch Health Recent Development Table 175. Key Raw Materials Table 176. Raw Materials Key Suppliers Table 177. Congestive Heart Failure Drugs Distributors List Table 178. Congestive Heart Failure Drugs Customers List Table 179. Research Programs/Design for This Report Table 180. Authors List of This Report Table 181. Secondary Sources Table 182. Primary Sources List of Figures Figure 1. Congestive Heart Failure Drugs Product Image Figure 2. Global Congestive Heart Failure Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Congestive Heart Failure Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Congestive Heart Failure Drugs Sales (2021-2032) & (K Tons) Figure 5. Global Congestive Heart Failure Drugs Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Congestive Heart Failure Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Capsule Image Figure 9. Tablets Image Figure 10. Injection Image Figure 11. Global Congestive Heart Failure Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 12. Global Congestive Heart Failure Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Congestive Heart Failure Drugs Sales Market Share by Type (2021-2032) Figure 14. Global Congestive Heart Failure Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 15. Global Congestive Heart Failure Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Congestive Heart Failure Drugs Revenue Market Share by Type (2021-2032) Figure 17. Clinic Image Figure 18. Hospital Image Figure 19. Household Image Figure 20. Other Image Figure 21. Global Congestive Heart Failure Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 22. Global Congestive Heart Failure Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Congestive Heart Failure Drugs Sales Market Share by Application (2021-2032) Figure 24. Global Congestive Heart Failure Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 25. Global Congestive Heart Failure Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Congestive Heart Failure Drugs Revenue Market Share by Application (2021-2032) Figure 27. North America Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 28. North America Congestive Heart Failure Drugs Sales Market Share by Country (2021-2032) Figure 29. U.S. Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 30. Canada Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 31. Mexico Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 32. Europe Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 33. Europe Congestive Heart Failure Drugs Sales Market Share by Country (2021-2032) Figure 34. Germany Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 35. France Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 36. U.K. Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 37. Italy Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 38. Netherlands Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 39. Asia Pacific Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 40. Asia Pacific Congestive Heart Failure Drugs Sales Market Share by Country (2021-2032) Figure 41. China Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 42. Japan Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 43. South Korea Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 44. Southeast Asia Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 45. India Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 46. Australia Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 47. South America, Middle East and Africa Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 48. South America, Middle East and Africa Congestive Heart Failure Drugs Sales Market Share by Country (2021-2032) Figure 49. Brazil Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 50. South Africa Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 51. Saudi Arabia Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 52. Turkey Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 53. Argentina Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 54. UAE Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 55. Egypt Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 56. Chile Congestive Heart Failure Drugs Sales and Growth Rate (2021-2032) & (K Tons) Figure 57. Global Congestive Heart Failure Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Congestive Heart Failure Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Congestive Heart Failure Drugs Revenue (2021-2032) & (US$ Million) Figure 60. North America Congestive Heart Failure Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Congestive Heart Failure Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Europe Congestive Heart Failure Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Congestive Heart Failure Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Congestive Heart Failure Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Congestive Heart Failure Drugs Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Congestive Heart Failure Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Congestive Heart Failure Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Congestive Heart Failure Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Tablets
  • Injection
Applications
  • Clinic
  • Hospital
  • Household
  • Other
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck & Co
  • Mylan
  • Pfizer
  • GSK
  • Bayer
  • AstraZeneca
  • Xudong Haipu Pharmaceutical
  • Xinhua Group
  • Sinepharm
  • NCPC
  • Lunan Pharmaceutical
  • Langtian
  • Hayao
  • Hai Ni Pharmaceutical
  • Exelixis
  • CRC
  • Bristol-Myers Squibb
  • Boehringer Inhelheim
  • Bausch Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Congestive Heart Failure Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Congestive Heart Failure Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Congestive Heart Failure Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Congestive Heart Failure Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Congestive Heart Failure Drugs Market Dynamics
  1. 2.1 Congestive Heart Failure Drugs Industry Trends
  2. 2.2 Congestive Heart Failure Drugs Industry Drivers
  3. 2.3 Congestive Heart Failure Drugs Industry Opportunities and Challenges
  4. 2.4 Congestive Heart Failure Drugs Industry Restraints
3 Congestive Heart Failure Drugs Market by Manufacturers
  1. 3.1 Global Congestive Heart Failure Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Congestive Heart Failure Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Congestive Heart Failure Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Congestive Heart Failure Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Congestive Heart Failure Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Congestive Heart Failure Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Congestive Heart Failure Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Congestive Heart Failure Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Congestive Heart Failure Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Congestive Heart Failure Drugs Tier 1, Tier 2, and Tier 3
4 Congestive Heart Failure Drugs Market by Type
  1. 4.1 Congestive Heart Failure Drugs Type Introduction
  2. 4.1.1 Capsule
  3. 4.1.2 Tablets
  4. 4.1.3 Injection
  5. 4.2 Global Congestive Heart Failure Drugs Sales by Type
  6. 4.2.1 Global Congestive Heart Failure Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Congestive Heart Failure Drugs Sales by Type (2021-2032)
  8. 4.2.3 Global Congestive Heart Failure Drugs Sales Market Share by Type (2021-2032)
  9. 4.3 Global Congestive Heart Failure Drugs Revenue by Type
  10. 4.3.1 Global Congestive Heart Failure Drugs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Congestive Heart Failure Drugs Revenue by Type (2021-2032)
  12. 4.3.3 Global Congestive Heart Failure Drugs Revenue Market Share by Type (2021-2032)
5 Congestive Heart Failure Drugs Market by Application
  1. 5.1 Congestive Heart Failure Drugs Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Household
  5. 5.1.4 Other
  6. 5.2 Global Congestive Heart Failure Drugs Sales by Application
  7. 5.2.1 Global Congestive Heart Failure Drugs Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Congestive Heart Failure Drugs Sales by Application (2021-2032)
  9. 5.2.3 Global Congestive Heart Failure Drugs Sales Market Share by Application (2021-2032)
  10. 5.3 Global Congestive Heart Failure Drugs Revenue by Application
  11. 5.3.1 Global Congestive Heart Failure Drugs Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Congestive Heart Failure Drugs Revenue by Application (2021-2032)
  13. 5.3.3 Global Congestive Heart Failure Drugs Revenue Market Share by Application (2021-2032)
6 Global Congestive Heart Failure Drugs Sales by Region
  1. 6.1 Global Congestive Heart Failure Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Congestive Heart Failure Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Congestive Heart Failure Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Congestive Heart Failure Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Congestive Heart Failure Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Congestive Heart Failure Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Congestive Heart Failure Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Congestive Heart Failure Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Congestive Heart Failure Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Congestive Heart Failure Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Congestive Heart Failure Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Congestive Heart Failure Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Congestive Heart Failure Drugs Revenue by Region
  1. 7.1 Global Congestive Heart Failure Drugs Revenue by Region
  2. 7.1.1 Global Congestive Heart Failure Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Congestive Heart Failure Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Congestive Heart Failure Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Congestive Heart Failure Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Congestive Heart Failure Drugs Revenue (2021-2032)
  8. 7.2.2 North America Congestive Heart Failure Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Congestive Heart Failure Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Congestive Heart Failure Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Congestive Heart Failure Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Congestive Heart Failure Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Congestive Heart Failure Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Congestive Heart Failure Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Congestive Heart Failure Drugs Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Congestive Heart Failure Drugs Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Congestive Heart Failure Drugs Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Merck & Co
  20. 8.4.1 Merck & Co Company Information
  21. 8.4.2 Merck & Co Business Overview
  22. 8.4.3 Merck & Co Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck & Co Congestive Heart Failure Drugs Product Portfolio
  24. 8.4.5 Merck & Co Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Congestive Heart Failure Drugs Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Congestive Heart Failure Drugs Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 GSK
  38. 8.7.1 GSK Company Information
  39. 8.7.2 GSK Business Overview
  40. 8.7.3 GSK Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GSK Congestive Heart Failure Drugs Product Portfolio
  42. 8.7.5 GSK Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Congestive Heart Failure Drugs Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 AstraZeneca
  50. 8.9.1 AstraZeneca Company Information
  51. 8.9.2 AstraZeneca Business Overview
  52. 8.9.3 AstraZeneca Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AstraZeneca Congestive Heart Failure Drugs Product Portfolio
  54. 8.9.5 AstraZeneca Recent Developments
  55. 8.10 Xudong Haipu Pharmaceutical
  56. 8.10.1 Xudong Haipu Pharmaceutical Company Information
  57. 8.10.2 Xudong Haipu Pharmaceutical Business Overview
  58. 8.10.3 Xudong Haipu Pharmaceutical Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Xudong Haipu Pharmaceutical Congestive Heart Failure Drugs Product Portfolio
  60. 8.10.5 Xudong Haipu Pharmaceutical Recent Developments
  61. 8.11 Xinhua Group
  62. 8.11.1 Xinhua Group Company Information
  63. 8.11.2 Xinhua Group Business Overview
  64. 8.11.3 Xinhua Group Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Xinhua Group Congestive Heart Failure Drugs Product Portfolio
  66. 8.11.5 Xinhua Group Recent Developments
  67. 8.12 Sinepharm
  68. 8.12.1 Sinepharm Company Information
  69. 8.12.2 Sinepharm Business Overview
  70. 8.12.3 Sinepharm Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sinepharm Congestive Heart Failure Drugs Product Portfolio
  72. 8.12.5 Sinepharm Recent Developments
  73. 8.13 NCPC
  74. 8.13.1 NCPC Company Information
  75. 8.13.2 NCPC Business Overview
  76. 8.13.3 NCPC Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 NCPC Congestive Heart Failure Drugs Product Portfolio
  78. 8.13.5 NCPC Recent Developments
  79. 8.14 Lunan Pharmaceutical
  80. 8.14.1 Lunan Pharmaceutical Company Information
  81. 8.14.2 Lunan Pharmaceutical Business Overview
  82. 8.14.3 Lunan Pharmaceutical Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Lunan Pharmaceutical Congestive Heart Failure Drugs Product Portfolio
  84. 8.14.5 Lunan Pharmaceutical Recent Developments
  85. 8.15 Langtian
  86. 8.15.1 Langtian Company Information
  87. 8.15.2 Langtian Business Overview
  88. 8.15.3 Langtian Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Langtian Congestive Heart Failure Drugs Product Portfolio
  90. 8.15.5 Langtian Recent Developments
  91. 8.16 Hayao
  92. 8.16.1 Hayao Company Information
  93. 8.16.2 Hayao Business Overview
  94. 8.16.3 Hayao Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Hayao Congestive Heart Failure Drugs Product Portfolio
  96. 8.16.5 Hayao Recent Developments
  97. 8.17 Hai Ni Pharmaceutical
  98. 8.17.1 Hai Ni Pharmaceutical Company Information
  99. 8.17.2 Hai Ni Pharmaceutical Business Overview
  100. 8.17.3 Hai Ni Pharmaceutical Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Hai Ni Pharmaceutical Congestive Heart Failure Drugs Product Portfolio
  102. 8.17.5 Hai Ni Pharmaceutical Recent Developments
  103. 8.18 Exelixis
  104. 8.18.1 Exelixis Company Information
  105. 8.18.2 Exelixis Business Overview
  106. 8.18.3 Exelixis Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Exelixis Congestive Heart Failure Drugs Product Portfolio
  108. 8.18.5 Exelixis Recent Developments
  109. 8.19 CRC
  110. 8.19.1 CRC Company Information
  111. 8.19.2 CRC Business Overview
  112. 8.19.3 CRC Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 CRC Congestive Heart Failure Drugs Product Portfolio
  114. 8.19.5 CRC Recent Developments
  115. 8.20 Bristol-Myers Squibb
  116. 8.20.1 Bristol-Myers Squibb Company Information
  117. 8.20.2 Bristol-Myers Squibb Business Overview
  118. 8.20.3 Bristol-Myers Squibb Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Bristol-Myers Squibb Congestive Heart Failure Drugs Product Portfolio
  120. 8.20.5 Bristol-Myers Squibb Recent Developments
  121. 8.21 Boehringer Inhelheim
  122. 8.21.1 Boehringer Inhelheim Company Information
  123. 8.21.2 Boehringer Inhelheim Business Overview
  124. 8.21.3 Boehringer Inhelheim Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Boehringer Inhelheim Congestive Heart Failure Drugs Product Portfolio
  126. 8.21.5 Boehringer Inhelheim Recent Developments
  127. 8.22 Bausch Health
  128. 8.22.1 Bausch Health Company Information
  129. 8.22.2 Bausch Health Business Overview
  130. 8.22.3 Bausch Health Congestive Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Bausch Health Congestive Heart Failure Drugs Product Portfolio
  132. 8.22.5 Bausch Health Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Congestive Heart Failure Drugs Value Chain Analysis
  2. 9.1.1 Congestive Heart Failure Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Congestive Heart Failure Drugs Production Mode & Process
  6. 9.2 Congestive Heart Failure Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Congestive Heart Failure Drugs Distributors
  9. 9.2.3 Congestive Heart Failure Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst